Related Experiment Video

Updated: Jun 3, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Cytoplasmic sequestration of wild-type p53 in a patient with therapy-related resistant AML: first report

Miron Prokocimer1, Shoshana Peller

  • 1Department of Hematology, Belinson Hospital, Rabin Medical Center, 49100 Petach-Tikva, Israel. prokocim@post.tau.ac.il

Medical Oncology (Northwood, London, England)
|March 29, 2011
PubMed

Insights

p53 protein inactivation in acute myeloid leukemia (AML) can occur through cytoplasmic mislocalization, not just TP53 mutations. This finding suggests a new diagnostic approach for AML treatment resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hematology

Background:

  • p53 inactivation is crucial in cancer development and treatment resistance.
  • In acute myeloid leukemia (AML), p53 inactivation typically involves TP53 mutations or pathway abrogation.
  • Cytoplasmic mislocalization of wild-type (wt) p53 has been observed in solid tumors, but not previously in AML.

Observation:

  • A patient with therapy-related resistant AML, monosomal karyotype, and wt TP53 was identified.
  • This patient exhibited cytoplasmic sequestration of the p53 protein.
  • This case suggests a novel mechanism for p53 inactivation in AML.

Findings:

  • Wild-type p53 protein was found sequestered in the cytoplasm of AML cells.
  • This cytoplasmic mislocalization effectively inactivates wt p53 function.
  • This represents a potential alternative mechanism to TP53 mutations for p53 inactivation in AML.

Implications:

  • Cytoplasmic sequestration of p53 may be an underdiagnosed mechanism of AML resistance.
  • Evaluating p53 subcellular localization could offer new diagnostic and therapeutic strategies for AML.
  • This finding necessitates further research in larger patient cohorts to confirm prevalence and clinical relevance.

More Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...